DekaBank Deutsche Girozentrale Buys 39,101 Shares of CME Group Inc. (NASDAQ:CME)

DekaBank Deutsche Girozentrale grew its stake in shares of CME Group Inc. (NASDAQ:CME) by 6.0% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 685,973 shares of the financial services provider’s stock after acquiring an additional 39,101 shares during the period. DekaBank Deutsche Girozentrale’s holdings in CME Group were worth $148,879,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of CME. CVA Family Office LLC increased its holdings in CME Group by 11.8% in the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after purchasing an additional 46 shares in the last quarter. Capital Advisors Ltd. LLC increased its stake in shares of CME Group by 4.3% in the first quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after buying an additional 48 shares during the period. Lester Murray Antman dba SimplyRich raised its holdings in CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after buying an additional 50 shares during the last quarter. Essex LLC boosted its position in CME Group by 3.3% during the 1st quarter. Essex LLC now owns 1,649 shares of the financial services provider’s stock worth $355,000 after buying an additional 52 shares during the period. Finally, Quent Capital LLC grew its holdings in CME Group by 10.2% during the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock worth $131,000 after acquiring an additional 55 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

CME has been the subject of several analyst reports. Oppenheimer raised their price target on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday. TD Cowen assumed coverage on shares of CME Group in a research note on Thursday, September 26th. They set a “hold” rating and a $221.00 target price for the company. Deutsche Bank Aktiengesellschaft upped their price target on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $235.00 target price on shares of CME Group in a report on Thursday. Finally, Morgan Stanley increased their price target on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $222.07.

CME Group Price Performance

Shares of NASDAQ CME opened at $226.14 on Friday. The company has a market capitalization of $81.43 billion, a PE ratio of 25.73, a PEG ratio of 7.76 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The stock’s 50 day moving average price is $218.94 and its 200-day moving average price is $208.89. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.36.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the previous year, the firm earned $2.25 earnings per share. The business’s revenue was up 18.4% on a year-over-year basis. On average, equities analysts anticipate that CME Group Inc. will post 10.04 EPS for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were given a dividend of $1.15 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.03%. CME Group’s payout ratio is currently 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.